arrow
P

Peter Schmidt

Technische Universität Dresden
H指数:22
被引数:2,250

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic Coronavirus Disease 2019: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)

帕米维伯特(Pemivibart)作为长效单克隆抗体预防有症状COVID-19的安全性与有效性:CANOPY临床试验的初步结果

2025-06-012
OAAI
Supplementing Best Care with Specialized Rehabilitation Treatment in Parkinson's Disease: A Retrospective Study by Different Expert Centers
2024-05-201
OAAI
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
2023-05-245
OAAI
Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m
2022-06-0110
PRE
Factors Associated With Acute Pain Estimation, Postoperative Pain Resolution, Opioid Cessation, and Recovery Secondary Analysis of a Randomized Clinical Trial
2019-03-0178
OAAI